180 related articles for article (PubMed ID: 19839533)
1. [Metabolic control in patients with type-1 and type-2 diabetes mellitus receiving ambulatory care from general practitioners: results of a cross-sectional trial performed in the German federal states of Thuringia and West Pomerania].
Schiel R; Netzer C; Junghänel J; Müller UA
Z Evid Fortbild Qual Gesundhwes; 2009; 103(7):453-60. PubMed ID: 19839533
[TBL] [Abstract][Full Text] [Related]
2. [Structured treatment and teaching programs and an improvement in private health care lead to a better quality of diabetes care. JEVIN, a population-based trial 1989/90 up to 1999/2000].
Schiel R; Müller UA
Med Klin (Munich); 2003 Jun; 98(6):303-12. PubMed ID: 12811414
[TBL] [Abstract][Full Text] [Related]
3. [Costs of therapy of insulin-treated patients with Diabetes mellitus in Germany. Results of the JEVIN trial].
Schiel R; Müller UA; Stein G
Med Klin (Munich); 2005 Aug; 100(8):453-61. PubMed ID: 16096726
[TBL] [Abstract][Full Text] [Related]
4. Structured diabetes therapy and education improves the outcome of patients with insulin treated diabetes mellitus. The 10 year follow-up of a prospective, population-based survey on the quality of diabetes care (the JEVIN Trial).
Schiel R; Voigt U; Ross IS; Braun A; Rillig A; Hunger-Dathe W; Stein G; Müller UA
Exp Clin Endocrinol Diabetes; 2006 Jan; 114(1):18-27. PubMed ID: 16450312
[TBL] [Abstract][Full Text] [Related]
5. Regional differences of glycaemic control in patients with type 2 diabetes mellitus in Switzerland: a national cross-sectional survey.
Gerber PA; Spirk D; Brändle M; Thoenes M; Lehmann R; Keller U
Swiss Med Wkly; 2011; 141():w13218. PubMed ID: 21735364
[TBL] [Abstract][Full Text] [Related]
6. Relationship between metabolic control and self-monitoring of blood glucose in insulin-treated patients with diabetes mellitus.
Soto González A; Quintela Fernández N; Pumar López A; Darias Garzón R; Rivas Fernández M; Barberá Comes G
Endocrinol Nutr; 2015 May; 62(5):233-9. PubMed ID: 25814324
[TBL] [Abstract][Full Text] [Related]
7. Validity of random blood glucose as a predictor of the quality of glycaemic control by glycated haemoglobin in out-patient diabetic patients at Kenyatta National Hospital.
Otieno FC; Ng'ang'a L; Kariuki M
East Afr Med J; 2002 Sep; 79(9):491-5. PubMed ID: 12625691
[TBL] [Abstract][Full Text] [Related]
8. [Hypoglycemia: danger to life of diabetic patients. Higher price for blood sugar adjustment].
Füessl HS
MMW Fortschr Med; 2005 Aug; 147(31-32):4-6, 8. PubMed ID: 16128187
[No Abstract] [Full Text] [Related]
9. [Mapping of HbA1c as a quality measure in the primary care of diabetic patients in Thuringia, Germany].
Sämann A; Köhler S; Klinger R; Mohr C; Müller UA
Z Arztl Fortbild Qualitatssich; 2002 Oct; 96(9):615-20. PubMed ID: 12474312
[TBL] [Abstract][Full Text] [Related]
10. [Optimised glycaemic control and dose titration with insulin glargine (Lantus) by general practitioners in Switzerland: results of the OPTI-LAN Postmarketing Study].
Spirk D; Lareida J; Scheidegger K; Diem P
Praxis (Bern 1994); 2009 Mar; 98(6):315-20. PubMed ID: 19291638
[TBL] [Abstract][Full Text] [Related]
11. [Prevalence, drug treatment and metabolic control of diabetes mellitus in primary care].
Pittrow D; Stalla GK; Zeiher AM; Silber S; März W; Pieper L; Klotsche J; Glaesmer H; Ruf G; Schneider HJ; Lehnert H; Böhler S; Koch U; Wittchen HU
Med Klin (Munich); 2006 Aug; 101(8):635-44. PubMed ID: 16896570
[TBL] [Abstract][Full Text] [Related]
12. Beyond HbA1c.
Bloomgarden Z
J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
[TBL] [Abstract][Full Text] [Related]
13. Impact and duration effect of telemonitoring on ΗbA1c, BMI and cost in insulin-treated Diabetes Mellitus patients with inadequate glycemic control: A randomized controlled study.
Fountoulakis S; Papanastasiou L; Gryparis A; Markou A; Piaditis G
Hormones (Athens); 2015; 14(4):632-43. PubMed ID: 26188234
[TBL] [Abstract][Full Text] [Related]
14. The importance of HbA1c and glucose variability in patients with type 1 and type 2 diabetes: outcome of continuous glucose monitoring (CGM).
Sartore G; Chilelli NC; Burlina S; Di Stefano P; Piarulli F; Fedele D; Mosca A; Lapolla A
Acta Diabetol; 2012 Dec; 49 Suppl 1():S153-60. PubMed ID: 22466072
[TBL] [Abstract][Full Text] [Related]
15. Treat-to-target HbA
Gagliardino JJ; Elgart J; Forti L; Guaita MS; Chantelot JM
Diabetes Metab Res Rev; 2019 Sep; 35(6):e3166. PubMed ID: 30963685
[TBL] [Abstract][Full Text] [Related]
16. Medical care of type 2 diabetes mellitus in light of international and national recommendations: a retrospective analysis.
Burgmann K; Fatio S; Jordi B; Rutishauser J
Swiss Med Wkly; 2013; 143():w13871. PubMed ID: 24163110
[TBL] [Abstract][Full Text] [Related]
17. Blood-glucose self-monitoring in insulin treated type 2 diabetes mellitus a cross-sectional study with an intervention group.
Schiel R; Müller UA; Rauchfub J; Sprott H; Müller R
Diabetes Metab; 1999 Sep; 25(4):334-40. PubMed ID: 10566123
[TBL] [Abstract][Full Text] [Related]
18. Assessment of metabolic control in patients with diabetes treated with insulin using Contour USB and A1cNow+ devices (COMET study).
Vinagre I; Álvarez P; García N; Roura G; Conget I;
Endocrinol Nutr; 2015 Oct; 62(8):384-90. PubMed ID: 26391507
[TBL] [Abstract][Full Text] [Related]
19. [The SPACE project (Stav Pacientů Akceptovaných diabetologem Cestou Exportu/The Health Records of Patients Accepted by a Diabetologist by way of Export)].
Kvapil M
Vnitr Lek; 2016; 62(9 Suppl 3):22-27. PubMed ID: 27734687
[TBL] [Abstract][Full Text] [Related]
20. Sensor and software use for the glycaemic management of insulin-treated type 1 and type 2 diabetes patients.
Ajjan RA; Abougila K; Bellary S; Collier A; Franke B; Jude EB; Rayman G; Robinson A; Singh BM
Diab Vasc Dis Res; 2016 May; 13(3):211-9. PubMed ID: 27000105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
